Ikarian Capital, LLC
- SEC CIK
- 0001778253
- 最新申報
- 2026/8/14
2024 年第 2 季持倉
持倉截至 2024/6/30，2024/8/14 申報。只含多頭部位，變化是跟 2024 年第 1 季比股數。
- 持股檔數
- 85
- 較 2024 年第 1 季 +3
- 總值
- $3.20 億
- 較 2024 年第 1 季 −$4,720 萬 (−12.8%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| SRPTSarepta Therapeutics, Inc. | COM | 203,612 | $3,217 萬 | 10.0% | +51,334+33.7% | 加碼 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 588,818 | $2,637 萬 | 8.2% | −54,933−8.5% | 減碼 | 歷史 |
| TARSTarsus Pharmaceuticals, Inc. | COM | 800,277 | $2,175 萬 | 6.8% | +90,000+12.7% | 加碼 | 歷史 |
| SLNOSoleno Therapeutics Inc | COM | 445,451 | $1,817 萬 | 5.7% | −119,960−21.2% | 減碼 | 歷史 |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | COM NEW | 309,540 | $1,401 萬 | 4.4% | −249,731−44.7% | 減碼 | 歷史 |
| ELVNEnliven Therapeutics, Inc. | COM | 586,552 | $1,371 萬 | 4.3% | +586,552 | 新進 | 歷史 |
| AMGNAmgen Inc | Stock | 38,300 | $1,197 萬 | 3.7% | +38,300 | 新進 | 歷史 |
| NUVLNuvalent, Inc. | COM | 151,601 | $1,150 萬 | 3.6% | +50,000+49.2% | 加碼 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 170,147 | $921.9 萬 | 2.9% | +25,000+17.2% | 加碼 | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 440,500 | $919.3 萬 | 2.9% | +140,500+46.8% | 加碼 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 332,013 | $841.0 萬 | 2.6% | +50,000+17.7% | 加碼 | 歷史 |
| CPRXCatalyst Pharmaceuticals, Inc. | COM | 518,386 | $803.0 萬 | 2.5% | 00.0% | 不變 | 歷史 |
| VKTXViking Therapeutics, Inc. | COM | 138,262 | $732.9 萬 | 2.3% | +138,262 | 新進 | 歷史 |
| IMVTImmunovant, Inc. | COM | 276,925 | $731.1 萬 | 2.3% | 00.0% | 不變 | 歷史 |
| RNACCartesian Therapeutics, Inc. | COM NEW | 242,370 | $654.6 萬 | 2.0% | +242,370 | 新進 | 歷史 |
| SLRNACELYRIN, Inc. | COM | 1,475,074 | $650.5 萬 | 2.0% | −89,266−5.7% | 減碼 | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 40,000 | $550.7 萬 | 1.7% | +40,000 | 新進 | 歷史 |
| PYXSPyxis Oncology, Inc. | COMMON STOCK | 1,662,408 | $550.3 萬 | 1.7% | 00.0% | 不變 | 歷史 |
| ARQTArcutis Biotherapeutics, Inc. | COM | 489,642 | $455.4 萬 | 1.4% | −100,000−17.0% | 減碼 | 歷史 |
| RCKTRocket Pharmaceuticals, Inc. | COM | 197,096 | $424.3 萬 | 1.3% | −100,000−33.7% | 減碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 107,187 | $417.9 萬 | 1.3% | 00.0% | 不變 | 歷史 |
| CRVOCervoMed Inc. | COM | 237,345 | $406.3 萬 | 1.3% | 00.0% | 不變 | 歷史 |
| RZLTRezolute, Inc. | COM NEW | 903,744 | $388.6 萬 | 1.2% | +903,744 | 新進 | 歷史 |
| Cybin Ord23256X100 | COM | 13,953,488 | $378.1 萬 | 1.2% | 00.0% | 不變 | – |
| LENZLENZ Therapeutics, Inc. | COM | 204,513 | $353.6 萬 | 1.1% | +119,513+140.6% | 加碼 | 歷史 |
| SLNSilence Therapeutics plc | ADS | 506,665 | $329.3 萬 | 1.0% | +506,665 | 新進 | 歷史 |
| INBXInhibrx Biosciences, Inc. | COM | 230,000 | $325.9 萬 | 1.0% | +230,000 | 新進 | 歷史 |
| ABEOAbeona Therapeutics Inc. | COM NEW | 768,593 | $325.9 萬 | 1.0% | −120,000−13.5% | 減碼 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 47,835 | $320.5 萬 | 1.0% | −3,500−6.8% | 減碼 | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 458,497 | $312.2 萬 | 1.0% | +370,000+418.1% | 加碼 | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 201,116 | $290.8 萬 | 0.9% | −174,194−46.4% | 減碼 | 歷史 |
| WVEWave Life Sciences, Inc. | SHS | 575,088 | $287.0 萬 | 0.9% | −15,000−2.5% | 減碼 | 歷史 |
| JSPRJasper Therapeutics, Inc. | COM NEW | 105,175 | $238.7 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| LRMRLarimar Therapeutics, Inc. | COM | 323,528 | $234.6 萬 | 0.7% | −115,000−26.2% | 減碼 | 歷史 |
| RCUSArcus Biosciences, Inc. | COM | 145,000 | $220.8 萬 | 0.7% | +145,000 | 新進 | 歷史 |
| QTTBQ32 Bio Inc. | COM | 109,094 | $195.8 萬 | 0.6% | +86,759+388.4% | 加碼 | 歷史 |
| ELEVElevation Acquisition Group Inc. | COM | 690,089 | $186.3 萬 | 0.6% | +542,000+366.0% | 加碼 | 歷史 |
| ANNXAnnexon, Inc. | COM | 380,000 | $186.2 萬 | 0.6% | −1,025,000−73.0% | 減碼 | 歷史 |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 302,908 | $183.0 萬 | 0.6% | +302,908 | 新進 | 歷史 |
| NKTRNektar Therapeutics | COM | 1,312,405 | $162.7 萬 | 0.5% | +1,312,405 | 新進 | 歷史 |
| SRRKScholar Rock Holding Corp | COM | 183,701 | $153.0 萬 | 0.5% | −108,000−37.0% | 減碼 | 歷史 |
| SGMTSagimet Biosciences Inc. | COM SER A | 412,565 | $141.1 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| TRMLTourmaline Bio, Inc. | COM | 108,483 | $139.5 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| IBIOiBio, Inc. | COM NEW | 600,000 | $126.6 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| IFRXInflaRx N.V. | COM | 704,987 | $122.7 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 1,443,181 | $117.6 萬 | 0.4% | 00.0% | 不變 | – |
| DFTXDefinium Therapeutics, Inc. | Stock | 162,481 | $117.1 萬 | 0.4% | −135,000−45.4% | 減碼 | 歷史 |
| ITOSiTeos Therapeutics, Inc. | COM | 78,574 | $116.6 萬 | 0.4% | −22,751−22.5% | 減碼 | 歷史 |
| KODKodiak Sciences Inc. | COM | 476,586 | $112.0 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| ROIVRoivant Sciences Ltd. | SHS | 100,609 | $106.3 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| NUVBNuvation Bio Inc. | COM CL A | 358,282 | $104.6 萬 | 0.3% | −275,000−43.4% | 減碼 | 歷史 |
| TECXTectonic Therapeutic, Inc. | COM | 62,836 | $103.5 萬 | 0.3% | 00.0% | 不變依 1 比 12 拆股換算 | 歷史 |
| VTYXVentyx Biosciences, Inc. | COM | 442,647 | $102.3 萬 | 0.3% | −65,000−12.8% | 減碼 | 歷史 |
| ALLKAllakos Inc. | COM | 972,675 | $97.3 萬 | 0.3% | +40,000+4.3% | 加碼 | 歷史 |
| MGNXMacrogenics Inc | COM | 200,079 | $85.0 萬 | 0.3% | −118,088−37.1% | 減碼 | 歷史 |
| DCTHDelcath Systems, Inc. | COM NEW | 100,370 | $84.0 萬 | 0.3% | +100,370 | 新進 | 歷史 |
| MRNSMarinus Pharmaceuticals, Inc. | COM NEW | 706,154 | $82.6 萬 | 0.3% | +168,229+31.3% | 加碼 | 歷史 |
| PRQRProQR Therapeutics N.V. | SHS EURO | 483,583 | $80.3 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| VERUVeru Inc. | COM | 946,382 | $79.6 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| LYELLyell Immunopharma, Inc. | COM | 526,066 | $76.3 萬 | 0.2% | +526,066 | 新進 | 歷史 |
| CLYMClimb Bio, Inc. | COM | 100,000 | $71.1 萬 | 0.2% | +100,000 | 新進 | 歷史 |
| AVTXAvalo Therapeutics, Inc. | COM NEW | 54,730 | $68.2 萬 | 0.2% | +8,082+17.3% | 加碼 | 歷史 |
| ABOSAcumen Pharmaceuticals, Inc. | COM | 266,435 | $64.5 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| MISTMilestone Pharmaceuticals Inc. | COM | 466,019 | $62.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| JBIOJade Biosciences, Inc. | COM | 367,965 | $61.1 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| IMTXImmatics N.V. | SHS | 49,415 | $57.4 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| IMUXImmunic, Inc. | COM | 493,496 | $54.8 萬 | 0.2% | −1,118,882−69.4% | 減碼 | 歷史 |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 274,551 | $52.2 萬 | 0.2% | −56,900−17.2% | 減碼 | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 868,992 | $52.1 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| RAPTRAPT Therapeutics, Inc. | COM | 154,625 | $47.2 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| VYGRVoyager Therapeutics, Inc. | COM | 55,857 | $44.2 萬 | 0.1% | −125,000−69.1% | 減碼 | 歷史 |
| ANEBAnebulo Pharmaceuticals, Inc. | COM | 157,862 | $43.1 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| FTHFaeth Therapeutics, Inc. | COM | 650,000 | $40.3 萬 | 0.1% | +650,000 | 新進 | 歷史 |
| TARAProtara Therapeutics, Inc. | COM STK | 180,712 | $37.6 萬 | 0.1% | −21,989−10.8% | 減碼 | 歷史 |
| NYXHNyxoah SA | COMMONSTOCK | 50,699 | $35.7 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| KPTIKaryopharm Therapeutics Inc. | COM | 409,355 | $35.5 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| LYRALyra Therapeutics, Inc. | COM | 1,056,829 | $29.2 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| AEONAEON Biopharma, Inc. | CL A | 257,977 | $27.1 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| TPSTTempest Therapeutics, Inc. | COM | 105,600 | $23.1 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| CMMBChemomab Therapeutics Ltd. | SPONSORED ADS | 213,392 | $19.6 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| RLMDRelmada Therapeutics, Inc. | COM | 40,369 | $12.1 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| STOKStoke Therapeutics, Inc. | COM | 6,816 | $9.21 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| SYBXSynlogic, Inc. | COM NEW | 20,448 | $3.07 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| BCLIBrainstorm Cell Therapeutics Inc. | COM NEW | 90,242 | $3.05 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| CTMXCytomX Therapeutics, Inc. | COM | 8,924 | $1.09 萬 | <0.1% | +8,924 | 新進 | 歷史 |
選擇權（20 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| ALNYAlnylam Pharmaceuticals, Inc. | COM | $3,645 萬 | $3,645 萬 |
| INSMINSMED Inc | COM PAR $.01 | $475.0 萬 | $3,397 萬 |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | $1,747 萬 | $1,241 萬 |
| AMGNAmgen Inc | Stock | – | $1,875 萬 |
| SRPTSarepta Therapeutics, Inc. | COM | – | $1,580 萬 |
| BBIOBridgeBio Pharma, Inc. | COM | – | $1,520 萬 |
| NBIXNeurocrine Biosciences Inc | Stock | – | $1,377 萬 |
| AREAlexandria Real Estate Equities, Inc. | COM | $857.4 萬 | – |
| AZNAstraZeneca PLC | SPONSORED ADR | – | $851.7 萬 |
| CORTCorcept Therapeutics Inc | COM | – | $604.3 萬 |
| GTHXG1 Therapeutics, Inc. | COM | $293.3 萬 | $279.3 萬 |
| VRDNViridian Therapeutics, Inc. | COM | $362.8 萬 | $130.1 萬 |
| SANASana Biotechnology, Inc. | COM | $218.4 萬 | $218.4 萬 |
| ANVSAnnovis Bio, Inc. | COM | $317.8 萬 | $29.8 萬 |
| IMVTImmunovant, Inc. | COM | – | $264.0 萬 |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | $113.9 萬 | $113.9 萬 |
| PYXSPyxis Oncology, Inc. | COMMON STOCK | – | $118.7 萬 |
| RAPTRAPT Therapeutics, Inc. | COM | – | $61.0 萬 |
| JBIOJade Biosciences, Inc. | COM | – | $16.6 萬 |
| ABEOAbeona Therapeutics Inc. | COM NEW | – | $7.25 萬 |
2024 年第 1 季之後清倉（13 檔）
2024 年第 1 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2024 年第 1 季股數 | 2024 年第 1 季市值 | 2024 年第 1 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| ALPNAlpine Immune Sciences, Inc. | COM | 261,365 | $1,036 萬 | 2.8% | 歷史 |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | 168,388 | $1,028 萬 | 2.8% | 歷史 |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 51,541 | $770.3 萬 | 2.1% | 歷史 |
| QUREuniQure N.V. | SHS | 469,133 | $243.9 萬 | 0.7% | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 35,092 | $206.3 萬 | 0.6% | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 140,687 | $198.0 萬 | 0.5% | 歷史 |
| IRONDisc Medicine, Inc. | COM | 25,372 | $158.0 萬 | 0.4% | 歷史 |
| HOOKHOOKIPA Pharma Inc. | COM | 530,776 | $37.8 萬 | 0.1% | 歷史 |
| EYPTEyePoint, Inc. | COM NEW | 1,047 | $2.16 萬 | <0.1% | 歷史 |
| FNCHFinch Therapeutics Group, Inc. | COM NEW | 6,892 | $1.81 萬 | <0.1% | 歷史 |
| TYRATyra Biosciences, Inc. | COM | 501 | $8,216 | <0.1% | 歷史 |
| Aslan Pharmaceuticals Ltd04522R200 | SPON ADS NEW | 35,420 | $6,273 | <0.1% | – |
| LBPHLongboard Pharmaceuticals, Inc. | COM | 236 | $5,098 | <0.1% | 歷史 |